GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeNeuro SA (CHIX:GNROp) » Definitions » Future Policy Benefits

GeNeuro (CHIX:GNROP) Future Policy Benefits


View and export this data going back to 2020. Start your Free Trial

What is GeNeuro Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.


GeNeuro Business Description

Traded in Other Exchanges
N/A
Address
3 chemin du Pre-Fleur, Plan-les-Ouates, Geneva, CHE, 1228
GeNeuro SA is a clinical-stage biopharmaceutical company focused on understanding and stopping causal factors driving the progression of neurodegenerative and autoimmune diseases. The company's therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family (W-ENV).